84-3385-28 [取扱停止]JAK1 (Janus Kinase 1, JAK-1, JAK1A, JAK1B, JTK3, Tyrosine-protein Kinase JAK1) (MaxLight 750) 100ul J0900-05C-ML750

※お見積書はカートで印刷できます

冷蔵

特徴

  • MaxLight™750 is a new Near IR stable dye conjugate comparable to DyLight™750, Alexa Fluor™700 and offers better labeling efficiency, brighter imaging and increased immunodetection.
  • Absorbance (759nm); Emission (780nm); Extinction Coefficient 240,000.
  • JAKs are non-receptor tyrosine kinases which couple to cytokine receptors, and are activated by cytokines.
  • They regulate a spectrum of cellular functions downstream of activated cytokine receptors in the lympho-hematopoietic system.
  • JAK kinases (JAK1, JAK2, JAK3, Tyk2) have a kinase domain and a second, pseudokinase domain which is not enzymatically active.
  • The principal effectors of JAKs are the STATs (Signal Transducers and Activators of Transcription), which are direct activators of transcription, but JAKs also signal to the Ras-MAP Kinase pathway, and through Tec, to the PI3 Kinase pathway.
  • Immunological stimuli induce recruitment of STAT transcription factors to cytokine receptor-associated JAK2 that becomes phosphoryated/activated on Tyr1007/10008.
  • JAK2 then phosphorylates proximal STAT transcription factors, which subsequently dimerize and translocate to the nucleus where they bind DNA.
  • The canonical JAK/Stat pathway is integral to maintaining a normal immune system by stimulating proliferation, differentiation, survival and host resistance to pathogens.
  • Altering JAK/Stat signaling to reduce cytokine induced pro-inflammatory responses represents an attractive target for anti-inflammatory therapies.
  • Within the JAK2 kinase domain, there is a region that has considerable sequence homology to the regulatory region of the insulin receptor.
  • Among a variety of sites, Tyrosines 1007 and 1008 (Tyr1007/1008) are sites of trans- or autophosphorylation in vivo and in vitro kinase reactions.
  • JAK2 is required for signaling through a different subset of cytokine receptors, while JAK1 is essential for signaling from the IL-2, IL-6 and interferon receptors.
  • JAK3 is required for signaling through cytokine receptors which share a common gamma-chain.
  • Applications:Suitable for use in Western Blot.
  • Other applications not tested.
  • Recommended Dilution:Western Blot: 1:500-1:1000 detects JAK1 on 10ug of PC12 lysates
  • Optimal dilutions to be determined by the researcher.
  • Positive Control:PC12 Cell Lysate
  • Storage and Stability:Store product at 4°C in the dark.
  • DO NOT FREEZE! Stable at 4°C for 12 months after receipt as an undiluted liquid.
  • Dilute required amount only prior to immediate use.
  • Further dilutions can be made in assay buffer.
  • Caution: MaxLight™750 conjugates are sensitive to light.
  • For maximum recovery of product, centrifuge the original vial prior to removing the cap.
  • Note: Applications are based on unconjugated antibody.

仕様

  • Size:100ul
  • Host:rabbit
  • Source Antibody:human
  • Grade:Affinity Purified
  • Purity:Purified by affinity chromatography.
  • Form:Supplied as a liquid in PBS, pH 7.2. No preservative added. Labeled with MaxLight™750.
  • Specificity:Recognizes human JAK1 at ~130kD. Does not react with JAK2. Species Crossreactivity: mouse and rat.
  • Isotype:IgG
  • Calc Applications Abbrev:WB
  • Calc Crossreactivity:Hu Mo Rt
  • Immunogen:Synthetic peptide corresponding to amino acids 1123-1141, CQPSNRTSFQNLIEGFEALLK of human JAK1. Cellular Localization: Intracytoplasmic membrane; Peripheral membrane protein.
  • Shelf Life:1year
  • Swiss Prot Number:P23458
  • EU Commodity Code:30021010
  • この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
  • 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
  • 【試薬に関するお問合せ】
  • アズワン株式会社 試薬・プロセス材料グループ
  • TEL:06-6447-8641
  • FAX:06-6447-8642
  • E-mail:[email protected]
アズワン品番
84-3385-28
型番
J0900-05C-ML750
入り数
1個
標準価格
193,000円(税抜)
WEB価格
取扱停止
アズワン在庫 [?]
数量

※お気に入り機能はログイン後にご利用いただけます

よくあるご質問

よくあるご質問(FAQ)

掲載カタログ情報

掲載カタログ名 掲載ページ

次の商品を登録しました。

商品計:

お買い物を続ける カートを見る